Perampanel treatment in Early-onset Epileptic Encephalopathy with infantile movement disorders associated with a de novo GRIN1 gene mutation: a 3-year follow-up

Neurol Sci. 2021 Apr;42(4):1627-1629. doi: 10.1007/s10072-020-04935-z. Epub 2021 Jan 5.

Authors

Daniela Dicanio^#¹, Antonio Gennaro Nicotera^#², F Cucinotta¹, G Di Rosa¹

Affiliations

¹ Unit of Child Neurology and Psychiatry, Department of Human Pathology of the Adult and Developmental Age, "Gaetano Barresi" University of Messina, Messina, 98125, Italy.
² Unit of Child Neurology and Psychiatry, Department of Human Pathology of the Adult and Developmental Age, "Gaetano Barresi" University of Messina, Messina, 98125, Italy. antonionicotera@ymail.com.

^# Contributed equally.

PMID: 33403508
DOI: 10.1007/s10072-020-04935-z

No abstract available

Publication types

Letter

MeSH terms

Follow-Up Studies
Humans
Infant
Movement Disorders* / complications
Movement Disorders* / drug therapy
Movement Disorders* / genetics
Mutation
Nerve Tissue Proteins / genetics
Nitriles
Pyridones
Receptors, N-Methyl-D-Aspartate / genetics
Spasms, Infantile*

Substances

GRIN1 protein, human
Nerve Tissue Proteins
Nitriles
Pyridones
Receptors, N-Methyl-D-Aspartate
perampanel